| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |